Ex­clu­sive: Ohana, Flag­ship's big bet on fer­til­i­ty treat­ments, shuts down and lays off staff af­ter VC pulls the plug

A lit­tle over a year af­ter emerg­ing from stealth, Flag­ship’s grand at­tempt to re­make fer­til­i­ty is shut­ting down.

Ohana Bio­sciences CEO Am­ber Salz­man con­firmed in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER